July 23, 2014 9:15 PM ET

Biotechnology

Company Overview of Adaptive Therapeutics, Inc.

Executive Profile

Pat N. Confalone Ph.D.

Member of Scientific Advisory Board, Adaptive Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Pat N. Confalone PhD served as Director of Medicinal Chemistry and Senior Vice President of Chemical Process R&D at Dupont Merck. Dr. Confalone recruited a world class Medicinal Chemistry department which discovered Cozaar™, a major anti-hypertensive based on angiotensin II antagonism. He joined Dupont Life Sciences where his Bioorganic Chemistry group developed the fluorescent dye-labeled reagents that were used in automated DNA sequencing, eventually employed in the ...

Corporate Headquarters

5820 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-909-9050
Fax: 858-909-0958

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Harvard University
BS
Massachusetts Institute of Technology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adaptive Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.